Logo
x

Search

Subscribe Now

Influenza

GSK Expand its 2020 Collaboration with Vir to Advance New Therapies for Influenza and Other Respiratory Viruses

GSK Expand its 2020 Collaboration with Vir to Advance New Therapies for Influenza and Other Respiratory Viruses

  • February 18, 2021
Roche's Xofluza Receives the EC's Approval for the Treatment of Influenza

Roche's Xofluza Receives the EC's Approval for the Treatment of Influenza

  • January 11, 2021
Roche's Xofluza (baloxavir marboxil) Receives the US FDA's Approval for Post-Exposure Prevention of Influenza

Roche's Xofluza (baloxavir marboxil) Receives the US FDA's Approval for Post-Exposure Prevention of Influenza

  • November 24, 2020
Sanofi's Supemtek (quadrivalent recombinant influenza vaccine) Receives the EC's Approval to Prevent Influenza

Sanofi's Supemtek (quadrivalent recombinant influenza vaccine) Receives the EC's Approval to Prevent Influenza

  • November 19, 2020
Roche's Xofluza (baloxavir marboxil) Receives CHMP's Recommendation for Approval to Treat Influenza

Roche's Xofluza (baloxavir marboxil) Receives CHMP's Recommendation for Approval to Treat Influenza

  • November 16, 2020
Sanofi's Supemtek Receives CHMP's Positive Opinion for Approval to Prevent Influenza

Sanofi's Supemtek Receives CHMP's Positive Opinion for Approval to Prevent Influenza

  • September 23, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.